Soft Tissue Repair Market

Global Soft Tissue Repair Market Size (2023 to 2028)

The global soft tissue repair market size is anticipated to grow at a 7.50% CAGR from 2023 to 2028. It is estimated that the global market is estimated worth USD 22.68 billion by 2028 and USD 15.8 billion in 2023.

MARKET DRIVERS:

The growing prevalence of sports activities and increased incidence of sprains and strains drive the growth of the soft tissue repair market.

The market growth is projected to drive by the growing need for soft tissue repair techniques in primary care settings. Soft tissue repair is frequently involved with significant consequences and, in unattended situations, might result in total failure. Soft tissue repair is prioritized in healthcare settings because of this. The introduction of biological grafts by significant manufacturers is gaining pace. Biological grafts offer a shorter recovery time and fewer problems related to rejection, which is expected to increase demand for these products. The soft tissue repair market is gradually shifting from traditional synthetic meshes to biological ones. Biocompatibility, strength, and aesthetics are all improved with these items. Growing awareness of the impact of these injuries on athletes' performance and awareness of available soft tissue repair therapy options is expected to drive the growth of the soft tissue repair market.

The growing number of patients suffering from sports-related injuries is boosting the soft tissue repair market growth.

Increased participation of children and adolescents in organized sports is projected to increase sports injuries. In addition, demand for goods is projected to rise as skilled physicians in soft tissue repair grow. Physicians are the actual medical equipment buyers, choosing the material, brand, and kind of tissue restoration operation. The rising number of physicians might expand the market for soft tissue repair products, resulting in overall growth. Traditional plastic meshes are being phased out in favor of biological meshes for soft tissue repair. Biocompatibility, strength, and aesthetics have all improved with these items. Obesity is on the rise, as are sports-related injuries, which is propelling the industry forward. Increased government and other organization funding are also assisting in the growth of this industry. New soft tissue healing procedures are being researched, as techniques involving synthetic and transplant materials have frequently failed. This is primarily due to a reduction in blood supply. The expansion of the soft tissue repair market is further aided by increased financing from the government and other organizations.  A growing number of operations, fueled by an aging population and an increase in trauma cases, is expected to drive demand for the global soft tissue repair market, providing manufacturers with attractive growth opportunities.

MARKET RESTRAINTS:

High costs and lack of favorable reimbursement policies hamper the soft tissue repair market growth. In addition, the lack of awareness among people regarding the advantages associated with soft tissue repair further inhibits the market’s growth rate. Furthermore, the lack of investments to conduct R&D in underdeveloped and developing countries further slows the market’s growth rate.

Impact of COVID-19 on the global soft repair tissue market:

COVID-19 is an unprecedented worldwide public health crisis that has impacted nearly every business, with long-term consequences expected to stifle the soft tissue repair market growth throughout the forecast period. SARS-CoV-2 is linked to physiologic alterations that may have an impact on healing. It's unclear whether these alterations enhance de novo wound formation or impede chronic wound healing in COVID-19-infected individuals. On the other hand, these alterations may exacerbate the already elevated risk of pressure-induced skin and soft tissue damage in COVID-19 patients who require extended hospitalization. In addition, market expansion may be hampered by a lack of awareness and restricted or non-existent reimbursement. As a result, COVID-19 quickly expanded to become a pandemic, creating significant disruptions in healthcare systems, particularly the care of patients with wounds.

REPORT COVERAGE:

This market research report on the global soft tissue repair market has been segmented and sub-segmented into the following categories.

Soft Tissue Repair Market – By Product:

• Mesh/Tissue Patch
  • Synthetic Mesh
  • Biological Mesh
    • Allograft
    • Xenograft
• Fixation Products
  • Suture Anchors
  • Interference Screws
  • Other Fixation Devices
• Laparoscopic Instruments

Based on the product, the tissue/mesh segment occupied the highest market share in the global soft tissue repair market in 2022.  The synthetic mesh dominated the segment within the sub-segments and estimated that dominance would continue. The biological mesh sub-segment is expected to showcase a healthy rate. This mesh is used to overcome the difficulties of synthetic meshes and offers mechanical support to the market. The Allograft sub-segment is observed to have lucrative growth as it is used in spinal fusion. It eliminates the need for extra surgical procedures and eliminates donor site problems such as infection.

The fixation products segment is estimated to exhibit a healthy CAGR during the forecast period due to the increasingly low cost of the products compared to tissue patches.

Soft Tissue Repair Market – By Application:

• Hernia Repair
• Dural Repair
• Vaginal Sling Procedures
• Skin Repair
• Orthopedic
• Dental
• Breast Reconstruction Repair

Based on the Application, the orthopedic surgery segment accounted for the leading shares in 2022. Factors such as the growing number of trauma cases and sports-related injuries, growing obesity rate, and healthcare expenditure worldwide surge the segment’s growth.

The breast reconstruction repair segment was occupied second in accounting for the leading share in 2022, followed by the orthopedic segment. An increasing number of women who have breast cancer and the number of reconstruction surgeries are estimated to fuel the market growth of soft tissue repair products, promoting the market growth.

Soft Tissue Repair Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, The soft tissue repair market in North America will dominate due to an increase in the demand for treatment and a rise in patients' awareness about different treatment options. In addition, an increase in medical tourism in developing countries, rising investment of market players in the Asia Pacific region, especially in India and China, and increasing health awareness about soft tissue repair treatment will drive the Asia Pacific market in the forecast period.

The European soft tissue repair market is also anticipated to grow significantly during the forecast period. The increasing concern regarding health among people and technological advancement in products will increase the demand for soft tissue repair treatment to fuel the market's growth.

The soft tissue repair market in APAC is driven by factors like the rising prevalence of soft tissue injuries among the active aging population, increased involvement in sports, rising obesity rates, rising healthcare expenditures, and the absence of alternatives for soft tissue repair operations.

Furthermore, The soft tissue repair market in Latin America, especially in Brazil, will be driven by government support for treatment and a rise in healthcare expenditure. In addition, an increase in disposable income and changing lifestyles among populations in developing economies, increasing hernia repairs, growing incidence of breast cancer, and an increase in the treatment option for aging, especially for the senior population and minimally invasive procedures, drive the market growth of soft tissue repair, globally.

The soft tissue repair market in the Middle East and Africa is also projected to have an inclined growth graph in the future period. With the rise in awareness of diagnosis and treatment procedures, the market is moving forward enormously. In addition, the evolution of technology and the rising geriatric population are expected to drive the MEA market.

KEY MARKET PARTICIPANTS:

A few noteworthy companies dominating the global soft tissue repair market profiled in this report are LifeCell Corporation, Organogenesis, C.R. Bard Inc., Johnson & Johnson, Covidien plc, Arthrex Inc., Smith & Nephew plc, Integra Lifesciences Corporation, Wright Medical Technology, and Stryker Corporation.

RECENT MARKET DEVELOPMENTS:

• In July 2020, Wright Medical launched the first shoulder arthroplasty procedure using its Blueprint mixed reality technology. Mixed reality is the new addition to Wright's Blueprint ecosystem. 
• In December 2020, Arthrex launched the first FDA-approved and cleared SwiveLock ACL Repair Kit. This is the first orthopedic company to develop and market the kit specifically for ACL repair. 
• In February 2020, Integra Life Sciences Corporation announced AmnioExcel + Placental Allograft Membrane's latest wound care offering in supporting soft tissue repair. The company is developing new regenerative technologies to treat soft tissue wounds and help patients recover quickly. 
• In September 2020, Smith + Nephew launched the CE mark-approved Novostitch Pro meniscal repair system. The system is used to repair meniscal tears and closes the gap present in the meniscectomy. In addition, Novostitch enables surgeons to place stitches arthroscopically. 
• In July 2016, Stryker invented SonicAnchor, a soft tissue fixation system used to repair surgeries that reattach tendons to bone. The implantation uses ultrasonic energy for more stability to hold.